Autonomix Medical Common Stock Statistics Share Statistics Autonomix Medical Common Stock has 5.15M
shares outstanding. The number of shares has increased by -87.93%
in one year.
Shares Outstanding 5.15M Shares Change (YoY) -87.93% Shares Change (QoQ) 12.89% Owned by Institutions (%) n/a Shares Floating 4.42M Failed to Deliver (FTD) Shares 7,908 FTD / Avg. Volume 0.57%
Short Selling Information The latest short interest is 330.65K, so 6.43% of the outstanding
shares have been sold short.
Short Interest 330.65K Short % of Shares Out 6.43% Short % of Float 7.09% Short Ratio (days to cover) 1.59
Valuation Ratios The PE ratio is -0.27 and the forward
PE ratio is -0.39.
Autonomix Medical Common Stock's PEG ratio is
0.
PE Ratio -0.27 Forward PE -0.39 PS Ratio 0 Forward PS n/a PB Ratio 0.38 P/FCF Ratio -0.37 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Autonomix Medical Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.63,
with a Debt / Equity ratio of 0.
Current Ratio 5.63 Quick Ratio 5.63 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -65.84
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.28M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -93.05% in the
last 52 weeks. The beta is -2.96, so Autonomix Medical Common Stock's
price volatility has been lower than the market average.
Beta -2.96 52-Week Price Change -93.05% 50-Day Moving Average 1.31 200-Day Moving Average 2.46 Relative Strength Index (RSI) 45.82 Average Volume (20 Days) 1,377,387
Income Statement
Revenue n/a Gross Profit -183K Operating Income -11.59M Net Income -11.41M EBITDA -11.05M EBIT -11.23M Earnings Per Share (EPS) -6.46
Full Income Statement Balance Sheet The company has 9.14M in cash and 0 in
debt, giving a net cash position of 9.14M.
Cash & Cash Equivalents 9.14M Total Debt n/a Net Cash n/a Retained Earnings -50.38M Total Assets 9M Working Capital 7.01M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.26M
and capital expenditures -14K, giving a free cash flow of -8.27M.
Operating Cash Flow -8.26M Capital Expenditures -14K Free Cash Flow -8.27M FCF Per Share -4.68
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
